BTSGBrightSpring Health Services, Inc.

$62.59

Price

$62.59+171%1Y
1M+3.3%1Y+171%

Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.

Smart Score

Average
6/10
Value20
Quality61
Momentum78
Growth69
Strongest Momentum, weakest Value · ranked vs Healthcare peers. The five questions below judge the company on its own terms.
What they do

We are a leading home and community-based healthcare services platform, focused on delivering complementary pharmacy and provider services to complex patients. We have a differentiated approach to care delivery, with an integrated and scaled model that addresses critical services that the highest-need and highest-cost patients require. With a focus on Senior and Specialty patients, which includes Behavioral populations, our platform provides pharmacy and provider services (both clinical and supportive care in nature) in lower-cost home and community settings largely to Medicare, Medicaid, and commercially-insured populations.

In the company’s own words · 10-K filed Feb 27, 2026 · SEC EDGAR

P/E (TTM)37.7
Market Cap$13.68B
1Y Return+171%
5Y Return-

Business segments

Q2 2026 · $3.87B

The company’s own SEC segment disclosure.

  • Medicare D$1.15B30%
  • Commercial Insurance$1.05B27%
  • Medicare C$653.7M17%
  • Service$466.0M12%
  • Medicaid$339.3M9%
  • Medicare A$136.3M4%
  • Other (2)$74.4M2%

BrightSpring Health Services, Inc. (BTSG) reported revenue of $3.87B in Q2 2026 (quarter ended Jun 30, 2026), up 23% from the same quarter a year earlier. That came with a gross margin of 13% and net income of $84M (2.2% of revenue). For the full year FY2025, revenue was $12.9B (+28% year on year) and net income $191M. Its largest product in Q2 2026 was Medicare D at $1.15B, 30% of the disclosed total, just ahead of Commercial Insurance at 27%.

Raw charts

11 series · TTM

As reported to the SEC, without any scoring.